Iron overload in the Asian community

Blood

Volumn 114, Issue 1, 2009, Pages 20-25

  Chun, Yu Lok ^a   Merryweather Clarke, Alison T ^a   Viprakasit, Vip ^a,b   Chinthammitr, Yingyong ^b   Srichairatanakool, Somdet ^c   Limwongse, Chanin ^b   Oleesky, David ^d   Robins, Anthony J ^d   Hudson, John ^d   Wai, Phyu ^d   Premawardhena, Anuja ^e   De Silva, H Janaka ^e   Dassanayake, Anuradha ^e   McKeown, Carole ^f   Jackson, Maurice ^g   Gama, Rousseau ^g,h   Khan, Nasaim ⁱ   Newman, William ⁱ   Banait, Gurvinder ^j   Chilton, Andrew ^k   Wilson Morkeh, Isaac ^k   Weatherall, David J ^a   Robson, Kathryn J H ^a   more..

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b MAHIDOL UNIVERSITY   (Thailand)

^c THAMMASAT UNIVERSITY   (Thailand)

^d MACCLESFIELD DISTRICT GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF KELANIYA   (Sri Lanka)

^f BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^g NEW CROSS HOSPITAL   (United Kingdom)

^h UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

ⁱ ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^j ROYAL BLACKBURN HOSPITAL   (United Kingdom)

^k Kettering General Hospital NHS Trust   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FERROPORTIN; HEPCIDIN; ANTIMICROBIAL CATIONIC PEPTIDE; CATION TRANSPORT PROTEIN; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN; METAL TRANSPORTING PROTEIN 1;

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; COMMUNITY; CONTROL GROUP; CONTROLLED STUDY; DEVELOPING COUNTRY; FEMALE; HEMOCHROMATOSIS; HUMAN; IRON DEFICIENCY; IRON OVERLOAD; MALE; MUTATION; PRIORITY JOURNAL; ADOLESCENT; AMINO ACID SEQUENCE; ASIA; ASIAN; CHILD; CONSANGUINITY; GENETICS; GENOTYPE; MIDDLE AGED; MOLECULAR GENETICS; PEDIGREE; PHENOTYPE; SEQUENCE HOMOLOGY;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; CATION TRANSPORT PROTEINS; CHILD; CONSANGUINITY; FEMALE; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON OVERLOAD; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE; PHENOTYPE; SEQUENCE HOMOLOGY, AMINO ACID; YOUNG ADULT;

EID: 67651018727     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-01-199109     Document Type: Article

References (47)

1. Papanikolaou G, Samuels ME, Ludwig EH, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet. 2004;36:77-82. (Pubitemid 38056211)
2. Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 2003;33:21-22. (Pubitemid 36068676)
3. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090-2093. (Pubitemid 40007660)
4. Babitt JL, Huang FW, Wrighting DM, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006;38:531-539.
5. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408. (Pubitemid 26256612)
6. Lanzara C, Roetto A, Daraio F, et al. Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood. 2004;103:4317-4321. (Pubitemid 38685379)
7. Mortimore M, Merryweather-ClarkeAT, Robson KJ, Powell LW. The haemochromatosis gene: a global perspective and implications for the Asia-Pacific region. J Gastroenterol Hepatol. 1999;14:838-843. (Pubitemid 29459791)
8. Tsui WM, Lam PW, Lee KC, et al. The C282Y mutation of the HFE gene is not found in Chinese haemochromatotic patients: multicentre retrospective study. Hong Kong Med J. 2000;6:153-158.
9. Shiono Y, Ikeda R, Hayashi H, et al. C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan. Intern Med. 2001;40:852-856.
10. Pointon JJ, Viprakasit V, Miles KL, et al. Hemochromatosis gene (HFE) mutations in South East Asia: a potential for iron overload. Blood Cells Mol Dis. 2003;30:302-306. (Pubitemid 36539432)
11. Viprakasit V, Vathesathokit P, Chinchang W, et al. Prevalence of HFE mutations among the Thai population and correlation with iron loading in haemoglobin E disorder. Eur J Haematol. 2004;73:43-49. (Pubitemid 38824189)
12. Thakur V, Guptan RC, Hashmi AZ, Sakhuja P, Malhotra V, Sarin SK. Absence of hemochromatosis associated Cys282Tyr HFE gene mutation and low frequency of hemochromatosis phenotype in nonalcoholic chronic liver disease patients in India. J Gastroenterol Hepatol. 2004;19:86-90. (Pubitemid 38130612)
13. Garewal G, Das R, Ahluwalia J, Marwaha RK. Prevalence of the H63D mutation of the HFE in north India: its presence does not cause iron overload in beta thalassemia trait. Eur J Haematol. 2005;74:333-336. (Pubitemid 40461154)
14. Agarwal S, Tewari D, Arya V, et al. Status of HFE mutation in thalassemia syndromes in north India. Ann Hematol. 2007;86:483-485. (Pubitemid 46863884)
15. Shukla P, Julka S, Bhatia E, Shah S, Nagral A, Aggarwal R. HFE, hepcidin and ferroportin gene mutations are not present in Indian patients with primary haemochromatosis. Natl Med J India. 2006;19:20-23.
16. Arden KE, Wallace DF, Dixon JL, et al. A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient. Gut. 2003;52:1215-1217. (Pubitemid 36877439)
17. Hayashi H, Wakusawa S, Motonishi S, et al. Genetic background of primary iron overload syndromes in Japan. Intern Med. 2006;45:1107-1111. (Pubitemid 44773958)
18. Hayashi H, Wakusawa S, Yano M, Okada T. Genetic background of Japanese patients with adult-onset storage diseases in the liver. Hepatol Res. 2007;37:777-783. (Pubitemid 47308217)
19. Wallace DF, Browett P, Wong P, Kua H, Ameratunga R, Subramaniam VN. Identification of ferroportin disease in the Indian subcontinent. Gut. 2005;54:567-568. (Pubitemid 40395516)
20. Agarwal S, Sankar VH, Tewari D, Pradhan M. Ferroportin (SLC40A1) gene in thalassemic patients of Indian descent. Clin Genet. 2006;70:86-87. (Pubitemid 44192744)
21. Weatherall DJ, Clegg JB. The Thalassaemia Syndromes. 4th ed. Oxford, England: Oxford Blackwell Science; 2001.
22. Stoltzfus RJ, Mullany L, Black RE. Iron deficiency anaemia. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, eds. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Vol 1. Geneva, Switzerland: World Health Organization; 2004:163-209.
23. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet. 1997;34:275-278.
24. Merryweather-ClarkeAT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ. Geography of HFE C282Y and H63D mutations. Genet Test. 2000;4:183-198. (Pubitemid 30618706)
25. Steiner M, Ocran K, Genschel J, et al.Ahomozygous HFE gene splice site mutation (IVS5+1 G/A) in a hereditary hemochromatosis patient of Vietnamese origin. Gastroenterology. 2002;122:789-795. (Pubitemid 34173831)
26. Sohda T, Okubo R, Kamimura S, Ohkawara T. Hemochromatosis with HFE gene mutation in a Japanese patient. Am J Gastroenterol. 2001;96:2487-2488. (Pubitemid 32769217)
27. Rochette J, Pointon JJ, Fisher CA, et al. Multicentric origin of hemochromatosis gene (HFE) mutations. Am J Hum Genet. 1999;64:1056-1062. (Pubitemid 30463036)
28. Hsu HC, Lin CK, Tsay SH, et al. Iron overload in Chinese patients with hemoglobin H disease. Am J Hematol. 1990;34:287-290. (Pubitemid 20223504)
29. Chim CS, Chan V, Todd D. Hemosiderosis with diabetes mellitus in untransfused Hemoglobin H disease. Am J Hematol. 1998;57:160-163. (Pubitemid 28096540)
30. Chen FE, Ooi C, Ha SY, et al. Genetic and clinical features of hemoglobin H disease in Chinese patients. N Engl J Med. 2000;343:544-550. (Pubitemid 30650749)
31. Chan V, Wong MS, Ooi C, et al. Can defects in transferrin receptor 2 and hereditary hemochromatosis genes account for iron overload in HbH disease? Blood Cells Mol Dis. 2003;30:107-111. (Pubitemid 36378872)
32. Lee PL, Beutler E, Rao SV, Barton JC. Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin. Blood. 2004;103:4669-4671.
33. Takagi J. Structural basis for ligand recognition by RGD (Arg-Gly-Asp)-dependent integrins. Biochem Soc Trans. 2004;32:403-406. (Pubitemid 38813524)
34. Pagani A, Silvestri L, Nai A, Camaschella C. Hemojuvelin N-terminal mutants reach the plasma membrane but do not activate the hepcidin response. Haematologica. 2008;93:1466-1472.
35. Silvestri L, Pagani A, Fazi C, et al. Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis. Blood. 2007;109:4503-4510. (Pubitemid 46743421)
36. Donovan A, Brownlie A, Zhou Y, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000;403:776-781. (Pubitemid 30111839)
37. McKie AT, Marciani P, Rolfs A, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000;5:299-309. (Pubitemid 30628088)
38. Devalia V, Carter K, Walker AP, et al. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood. 2002;100:695-697. (Pubitemid 34761138)
39. Liu XB, Yang F, Haile DJ. Functional consequences of ferroportin 1 mutations. Blood Cells Mol Dis. 2005;35:33-46.
40. De Domenico I, Nemeth E, Nelson JM, et al. The hepcidin-binding site on ferroportin is evolutionarily conserved. Cell Metab. 2008;8:146-156.
41. Drakesmith H, Schimanski LM, Ormerod E, et al. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood. 2005;106:1092-1097. (Pubitemid 41076459)
42. Schimanski LM, Drakesmith H, Merryweather-Clarke AT, et al. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood. 2005;105:4096-4102.
43. Barton JC, Bertoli LF, Rothenberg BE. Peripheral blood erythrocyte parameters in hemochromatosis: evidence for increased erythrocyte hemoglobin content. J Lab Clin Med. 2000;135:96-104.
44. Bhansali A, Banerjee PK, Dash S, Radotra B, Dash RJ. Pituitary and testicular involvement in primary haemochromatosis. A case report. J Assoc Physicians India. 1992;40:757-759.
45. Hachiya M, Watanabe H, Tsukimoto I, Fujisawa T. Hereditary hemochromatosis not associated with common HFE gene mutation in Japanese siblings. J Pediatr Gastroenterol Nutr. 2001;32:501-503.
46. Kng C, Ng FH, Ng WF, et al. A Chinese patient with non-HFE-linked iron overload. J Clin Gastroenterol. 2001;33:69-71. (Pubitemid 32613584)
47. Panigrahi I, Ahmad F, Kapoor R, Sharma PK, Makharia G, Saxena R. Evidence for non-HFE linked hemochromatosis in Asian Indians. Indian J Med Sci. 2006;60:491-495. (Pubitemid 44934996)